Health Care & Life Sciences » Pharmaceuticals | Korean Drug Co. Ltd.

Korean Drug Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
3,272
3,272
3,569
3,994
3,149
Total Accounts Receivable
32,362
31,007
26,659
32,334
36,099
Inventories
8,823
9,540
9,918
8,318
9,074
Other Current Assets
135
128
290
276
408
Total Current Assets
44,591
43,947
40,437
44,922
48,730
Net Property, Plant & Equipment
15,580
15,223
14,919
14,565
14,878
Total Investments and Advances
1,283
1,904
2,595
1,942
963
Intangible Assets
294
757
903
807
845
Other Assets
1,793
343
344
1,170
1,021
Total Assets
63,542
62,175
59,197
63,411
66,794
ST Debt & Current Portion LT Debt
7,000
4,500
2,500
500
1,000
Accounts Payable
2,245
2,649
2,733
3,400
3,458
Income Tax Payable
5
115
187
1,016
934
Other Current Liabilities
1,659
2,042
1,888
3,118
3,210
Total Current Liabilities
10,909
9,307
7,308
8,034
8,602
Long-Term Debt
3,000
2,000
500
500
-
Provision for Risks & Charges
1,889
1,862
1,462
1,089
1,090
Deferred Taxes
216
110
145
6
356
Other Liabilities
105
105
105
127
129
Total Liabilities
16,119
13,384
9,519
9,749
9,821
Common Equity (Total)
47,423
48,791
49,679
53,662
56,973
Total Shareholders' Equity
47,423
48,791
49,679
53,662
56,973
Total Equity
47,423
48,791
49,679
53,662
56,973
Liabilities & Shareholders' Equity
63,542
62,175
59,197
63,411
66,794

About Korean Drug Co.

View Profile
Address
69-10 Wonjeok-ro
Icheon GY 17303
Korea, Republic Of
Employees -
Website http://www.nicepharma.com
Updated 09/14/2018
Korean Drug Co., Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. Its products are divided into the following categories: Over-The-Counter (OTC), ETC and Health Foods. Its products include remedies for respiratory diseases, topical agents for dermatoses, antibiotics and chemotherapeutics, hypnotics, antiulcer agents, antihistaminic, amino acid nutrients, antifungal agents and home pregnancy test kit.